- Home
- ALLT vs PROC Comparison
ALLT vs PROC Comparison
Compare ALLT & PROC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLT
- PROC
- Stock Information
- Founded
- ALLT 1996
- PROC 1976
- Country
- ALLT Israel
- PROC Luxembourg
- Employees
- ALLT N/A
- PROC N/A
- Industry
- ALLT Telecommunications Equipment
- PROC Biotechnology: Pharmaceutical Preparations
- Sector
- ALLT Telecommunications
- PROC Health Care
- Exchange
- ALLT Nasdaq
- PROC Nasdaq
- Market Cap
- ALLT 269.5M
- PROC 253.9M
- IPO Year
- ALLT 2006
- PROC N/A
- Fundamental
- Price
- ALLT $7.81
- PROC $1.65
- Analyst Decision
- ALLT Buy
- PROC
- Analyst Count
- ALLT 1
- PROC 0
- Target Price
- ALLT $13.00
- PROC N/A
- AVG Volume (30 Days)
- ALLT 1.1M
- PROC 31.5K
- Earning Date
- ALLT 02-25-2025
- PROC 01-01-0001
- Dividend Yield
- ALLT N/A
- PROC N/A
- EPS Growth
- ALLT N/A
- PROC N/A
- EPS
- ALLT N/A
- PROC 0.52
- Revenue
- ALLT $91,631,000.00
- PROC $414,096,000.00
- Revenue This Year
- ALLT $0.41
- PROC $5.54
- Revenue Next Year
- ALLT $8.84
- PROC $8.54
- P/E Ratio
- ALLT N/A
- PROC $3.32
- Revenue Growth
- ALLT N/A
- PROC N/A
- 52 Week Low
- ALLT $1.61
- PROC $0.50
- 52 Week High
- ALLT $8.15
- PROC $4.38
- Technical
- Relative Strength Index (RSI)
- ALLT 71.69
- PROC 41.20
- Support Level
- ALLT $6.51
- PROC $2.21
- Resistance Level
- ALLT $7.76
- PROC $1.80
- Average True Range (ATR)
- ALLT 0.69
- PROC 0.17
- MACD
- ALLT 0.05
- PROC -0.08
- Stochastic Oscillator
- ALLT 86.03
- PROC 17.05
About ALLT Allot Ltd.
Allot Ltd is a provider of network intelligence and security solutions for service providers and enterprises. The company's solutions are deployed globally for network and application analytics, traffic control and shaping, and network-based security services. The firm's multi-service platforms are deployed by mobile, fixed, and cloud service providers and enterprises. It has a customer base in Europe, Asia and Oceania, the Americas, the Middle East, and Africa.
About PROC Procaps Group S.A.
Procaps Group SA is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. It develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements, and high-potency clinical solutions. The company's segment includes NextGel; Procaps Colombia; CAN; CASAND and Diabetrics. It generates maximum revenue from the Procaps Colombia segment.